Bristol Myers Squibb Receives European Commission Approval of Zeposia for use in Adults with Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BMY, CTXS, OWLT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
BioHarvest Sciences New 20 Tons per Year Factory Obtains the GMP Certification from the Israeli Ministry of Health Biotech Investing
BMY, EAR, HEPS, HMLP INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting Pharmaceutical Investing
Gilead Submits Biologics License Application to U.S. Food and Drug Administration for Bulevirtide, an Investigational Treatment for People Living With Chronic Hepatitis Delta Pharmaceutical Investing
New Literature Review Highlights Economic Benefits Associated with Achieving Rheumatoid Arthritis Remission Pharmaceutical Investing
BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site for its Phase I/IIa Breast Cancer Study Biotech Investing
AbbVie Announces First Provincial Reimbursement for VENCLEXTA® with Obinutuzumab for Patients with Previously Untreated Chronic Lymphocytic Leukemia in Quebec Pharmaceutical Investing
